Published in Biol Psychiatry on August 01, 1983
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
Peptidase-deficient mutants of Escherichia coli. J Bacteriol (1978) 2.57
Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry (1989) 2.41
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. Br J Cancer (2003) 2.38
Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A (1997) 2.36
The Distress and Risk Assessment Method. A simple patient classification to identify distress and evaluate the risk of poor outcome. Spine (Phila Pa 1976) (1992) 2.16
Basal cortisol levels and cognitive deficits in human aging. J Neurosci (1994) 1.97
Surgery for lumbar spinal stenosis in old people. J Bone Joint Surg Br (1993) 1.87
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol (1999) 1.84
Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab (1997) 1.56
Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci (1999) 1.47
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study Group. Neurology (1996) 1.45
Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry (1990) 1.39
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. Br J Haematol (1994) 1.38
Genital infections with Chlamydia trachomatis in women attending an antenatal clinic. Br J Obstet Gynaecol (1984) 1.17
The role of denial in recovery from coronary heart disease. Psychosom Med (1987) 1.17
Studies on the synthesis of insulin from natural and synthetic A and B chains. II. Isolation of insulin from recombination mixtures of natural A and B chains. Biochemistry (1967) 1.14
Enkephalinase: selective peptide inhibitors. Life Sci (1981) 1.12
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil. J Clin Oncol (1996) 1.12
Preseptal and orbital cellulitis in childhood. A changing microbiologic spectrum. Ophthalmology (1998) 1.12
Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor. J Pharmacol Exp Ther (1997) 1.11
Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes. Diabetologia (1986) 1.11
A single origin of phenylketonuria in Yemenite Jews. Nature (1990) 1.11
Safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8055 in advanced solid tumours and lymphoma. Br J Cancer (2012) 1.09
Positive allosteric modulators of the GABA(A) receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol. Psychopharmacology (Berl) (1999) 1.07
Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res (1993) 1.07
Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging (1996) 1.07
Electroencephalograms and autopsy findings in geropsychiatry. J Gerontol (1978) 1.06
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial. Acta Psychiatr Scand Suppl (1990) 1.05
The use of the pain drawing as a screening measure to predict psychological distress in chronic low back pain. Spine (Phila Pa 1976) (1995) 1.04
Multiple opiate receptors: differential binding of mu, kappa and delta agonists. Neuropharmacology (1981) 1.04
Prevalence of tardive dyskinesia in affective disorder patients. J Clin Psychiatry (1983) 1.03
Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2. Blood (1998) 1.02
Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis (2007) 1.02
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancer. Br J Cancer (2011) 0.99
Late-onset bipolar disorder. Psychiatr Clin North Am (1988) 0.99
Histamine-activated, non-selective cation currents and Ca2+ transients in endothelial cells from human umbilical vein. Pflugers Arch (1993) 0.98
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer. J Clin Oncol (1997) 0.98
Individual differences in hypothalamic-pituitary-adrenal activity in later life and hippocampal aging. Exp Gerontol (1995) 0.97
Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse (1989) 0.97
Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593. Psychopharmacology (Berl) (1997) 0.96
Phase I and pharmacokinetic study of BMS-184476, a taxane with greater potency and solubility than paclitaxel. J Clin Oncol (2001) 0.95
A DR3-related DX alpha gene polymorphism strongly associates with insulin-dependent diabetes mellitus. Immunogenetics (1986) 0.95
Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo. Neuropharmacology (1991) 0.95
Nature of the B10 amino acid residue. Requirements for high biological activity of insulin. Int J Pept Protein Res (1984) 0.94
Role of the central benzodiazepine receptor system in behavioral habituation to novelty. Behav Neurosci (1989) 0.94
Reinforcing and discriminative stimulus effects of the neuroactive steroids pregnanolone and Co 8-7071 in rhesus monkeys. Psychopharmacology (Berl) (1999) 0.94
Increased rate of rapid axonal transport in vitamin E deficient rats. Brain Res (1975) 0.94
A five-year outcome of discharged chronic psychiatric patients. Can Psychiatr Assoc J (1972) 0.94
Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience (1986) 0.94
Apomorphine-induced penile tumescence in impotent patients--preliminary findings. Prog Neuropsychopharmacol Biol Psychiatry (1987) 0.94
Apomorphine: clinical studies on erectile impotence and yawning. Prog Neuropsychopharmacol Biol Psychiatry (1989) 0.94
Diazepam in high doses is effective in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.93
Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci (2001) 0.93
Multiple opiate receptors: support for unique mu, delta and kappa sites. Neuropharmacology (1982) 0.92
Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat. J Pharmacol Exp Ther (1986) 0.92
Characterization of peripheral benzodiazepine type sites in a cultured murine BV-2 microglial cell line. Glia (1996) 0.91
A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors. Cancer (1994) 0.91
Effects of caffeine in chronic psychiatric patients. Am J Psychiatry (1979) 0.90
Phase I and pharmacokinetic study of NSC 655649, a rebeccamycin analog with topoisomerase inhibitory properties. J Clin Oncol (2001) 0.89
Alzheimer's disease may not be a spirochetosis. Neuroreport (1999) 0.89
Circadian rhythm of plasma melatonin in endogenous depression. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.89
Peripheral benzodiazepine binding sites in Alzheimer's disease frontal and temporal cortex. Neurobiol Aging (1991) 0.89
Changes of hippocampal Met-enkephalin content after recurrent motor seizures. Nature (1980) 0.89
Intensive combined modality therapy for limited-stage small-cell lung cancer. J Natl Cancer Inst (1993) 0.88
Antidepressant--anxiolytic interaction: decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressants. Eur J Pharmacol (1984) 0.88
A phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (Genasense, G3139) and irinotecan in patients with metastatic colorectal cancer. Ann Oncol (2005) 0.88
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. J Clin Oncol (1994) 0.88
Differential effect of unilateral and bilateral ECT. Am J Psychiatry (1970) 0.88
Investigation of sexual dimorphism in the rabbit masseter muscle showing different effects of androgen deprivation in adult and young adult animals. Arch Oral Biol (2000) 0.87
Development of a novel helicase assay using electrochemiluminescence. Anal Biochem (2001) 0.87
Sexual dimorphism in the rabbit masseter muscle: myosin heavy chain composition of neuromuscular compartments. Cells Tissues Organs (1999) 0.87
Sigma receptors modulate the hypothalamic-pituitary-adrenal (HPA) axis centrally: evidence for a functional interaction with NMDA receptors, in vivo. Neuropharmacology (1990) 0.87
Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides. J Am Acad Dermatol (1998) 0.87
Changing patterns of hearing-aid use and level of support. Br J Audiol (1984) 0.87
Spinal analgesia: comparison of the mu agonist morphine and the kappa agonist ethylketazocine. Life Sci (1981) 0.87
The bioavailability and pharmacokinetics of oral and depot intramuscular haloperidol in schizophrenic patients. J Clin Pharmacol (1987) 0.87
Reduced lumbar CSF somatostatin levels in Alzheimer's disease. Life Sci (1982) 0.87
Effect of sleep deprivation on dopamine receptor function in normal subjects. J Neural Transm (1981) 0.86
Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency. J Med Chem (1992) 0.86
Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies. Eur J Cancer (1997) 0.86
Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets. Biol Psychiatry (1994) 0.86
Benzodiazepine interactions with central thyroid-releasing hormone binding sites: characterization and physiological significance. J Pharmacol Exp Ther (1986) 0.86
Kyotorphin (tyrosine-arginine): further evidence for indirect opiate receptor activation. Life Sci (1982) 0.86
Lactose malabsorption is not a cause of diarrhea during phototherapy. J Pediatr Gastroenterol Nutr (1985) 0.86
Mu opiate isoreceptors: differentiation with kappa agonists. Life Sci (1983) 0.86
Approach to the patient with a fatty acid oxidation disorder. Prog Clin Biol Res (1992) 0.86
Opioid regulation of CNS dopaminergic pathways: a review of methodology, receptor types, regional variations and species differences. Peptides (1984) 0.86
Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides. Brain Res (1987) 0.85